NextPharma
Private Company
Funding information not available
Overview
NextPharma is a Paris-based, private CDMO that has grown organically and through acquisitions since its founding in 2003. It offers a comprehensive suite of services including pharmaceutical development, clinical trial supply services, commercial manufacturing, and analytical services for both pharmaceuticals and nutritional supplements. The company is strategically positioning itself as a leading European pure-play CDMO, as evidenced by its recent divestiture of its logistics arm to sharpen this focus. Under new CEO Ajeeth Enjeti, NextPharma aims to leverage its customer-centric values and operational agility to drive sustainable growth.
Technology Platform
Integrated CDMO services platform encompassing pharmaceutical development, clinical trial manufacturing/packaging, commercial manufacturing, and analytical services for pharmaceuticals and health & nutrition products.
Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive global CDMO market, competing against large players like Lonza, Catalent, and Thermo Fisher Scientific, as well as many regional and niche specialists. Its strategy to be a leading European pure-play CDMO differentiates it from diversified conglomerates and logistics-heavy service providers.